The year 2020 was extraordinary for everyone. Although COVID-19 also affected Oncode, we are proud to share the successes we achieved in 2020. By further building on our three pillars - scientific excellence, collaboration, and valorization - all the hard work of our community in the last years starts to bear fruits.
To get a sneak peek: the Oncode community published 375 peer reviewed publications, Oncode has funded thirteen Clinical Proof of Concept studies to date and seven state-of-the-art technology driven Oncode core-facilities are now operational. And there is more. The fifth Oncode spin-off saw the light of day, over a 1000 people attended our meetings, Oncode’s strategic funding programme has a success rate of 35% and the valorization team brokered 183 research related agreements with industry in 2020.
Impressive results. And these are not our words, but the conclusion of the International Review Committee which visited us at the end of last year. It makes us eager to continue our efforts to provide our community with the tools and means to perform transformative research in 2021.
We invite you to read our full report about our results in 2020 and what we are planning for the future. We will take you through the highlights of each of our strategic pillars, and along the way, you also get to know three of our talented Oncode Investigators a bit better as they share their experiences in working within Oncode.
Read the report online on any device and let us know if you have any questions.